Work on the establishment of Acteryon Research and Development Center began in September 2019.

The R&D unit is housing departments responsible for phage hunt and characterization, lab testing of phage biological activities, new product development, product formulation to specific therapeutic or preventive indication and production optimization. Manufacturing facilities will be located next to the lab suits to enable production to GMP and GLP standard.

The technical and technological facilities of the Center and the constantly improved Acteryon’s know-how enable execution and implementation of projects and specialized commissioned tasks in an aerobic, microaerophilic and anaerobic environment.

We are constantly increasing our large phage collection at Acteryon – a key resource for future platforms and projects. At the end of 2024 the number of microbiologically, molecularly and bioinformatically tested and deposited in our collection number of bacteriophage strains exceeded 200.